Actin vs Corsica Health
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Actin
Best for affordable compounded semaglutide with B12 enhancementStarting at $133/mo
Corsica Health
Best for patients who want a single platform offering both compounded and brand-name GLP-1 options with publicly-disclosed pricing for direct comparisonStarting at $299/mo
Side-by-Side Comparison
| Feature | Actin | Corsica Health |
|---|---|---|
| Overall Score | 7.0/10 | ✓7.5/10 |
| Starting Price | ✓$133/mo | $299/mo |
| Editorial Rating | 3.5 ★ /5 | ✓3.8 ★ /5 |
| Features | 2 features | ✓9 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Actin
Pros
- ✓Semaglutide + B12 combination for added energy support
- ✓Transparent pricing — exact cost shown upfront with no hidden fees
- ✓Competitive starting price from $133
Cons
- ✗Semaglutide only — no tirzepatide or liraglutide
- ✗No visible LegitScript or PCAB accreditation
- ✗State availability not disclosed
- ✗Broader platform (hormones, sexual wellness, hair health)
Corsica Health
Pros
- ✓Public pricing disclosure for BOTH compounded and brand-name SKUs on marketing site — material YMYL transparency advantage vs peers
- ✓$299/month compounded semaglutide and $399/month compounded tirzepatide are in the median range for compounded telehealth
- ✓$1,499/month brand-name Wegovy/Ozempic/Mounjaro pricing is below typical retail cash-pay (~$1,300-$1,800)
- ✓LegitScript-approved seal displayed with verification link
- ✓Structured 3-step intake (Assessment → Provider Review → Receive Medication) clearly disclosed
Cons
- ✗Specific legal entity name + state of incorporation NOT publicly disclosed on the home page
- ✗Pharmacy partners described as 'licensed compounding pharmacy' but specific name NOT disclosed
- ✗Per-state availability NOT enumerated publicly
- ✗Zepbound and Foundayo NOT mentioned in the brand-name lineup (only Wegovy/Ozempic/Mounjaro)
- ✗First-month promotional pricing NOT disclosed (assumed steady-state from day one)
- ✗Lab work inclusion NOT clearly disclosed in marketing copy
Our Verdict
Corsica Health edges out Actin with a higher overall score of 7.5/10 and is particularly strong for patients who want a single platform offering both compounded and brand-name GLP-1 options with publicly-disclosed pricing for direct comparison. Actin remains a solid alternative, especially if you're looking for affordable compounded semaglutide with B12 enhancement.
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.